Sarcoma trials in Japan

In Japan 15 Also abroad 605

15 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
Where
Gifu, Hiroshima, Hyōgo, Ōita
Age
18 years and over
People
400 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07541170 · EU 2025-524263-21-01
Phase 1Taking people
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Where
Chūōku
Age
18 years and over
People
65 worldwide
Run by
EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT06641908 · EU 2024-513687-26-00
Phase 2Taking people
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Where
Chuo Ku, Kashiwa, Koto-ku, Nagoya, Sakai, Sapporo
Age
18 years and over
People
111 worldwide
Run by
Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00
Phase 1/2Taking people
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Where
Kashiwa
Age
18 years and over
People
430 worldwide
Run by
Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00
Phase 3Taking people
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Where
Bunkyo, Chiba, Fukuoka, Hirakata, Hiroshima, Kanazawa, Kashiwa, Kawasaki, Kitaadachi-gun, Kumamoto, Kurume, Matsusaka, Matsuyam, Nagoya, Natori-shi, Niigata, Osaka, Ōta, Ōta-ku, Sapporo, Sendai, Shinjuku, Takatsuki, Toyoake
Age
18 years and over
People
348 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00
Phase 3Taking people
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Where
Chikusa-ku, Chuo Ku, Higashiku, Kita-ku, Koto-Ku, Niigata, Saitama, Sendai, Shōwaku, Yokohama
Age
18 years and over
People
250 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04031677
Phase 1/2Taking people
A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma.
Where
Chiba, Chuo Ku, Fukuoka, Hiroshima, Kanazawa, Kashiwa, Kyoto, Okayama, Osaka, Sakai, Sapporo, Sendai, Sunto-gun, Tsu, Yokohama
Age
12 years and over
People
50
Run by
Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT07734116
Phase 1/2Taking people
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
Where
Fukuoka, Hokkaido, Tokyo
People
64 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07602777
Phase 3Taking people
Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma
Where
Fukuoka, Kashiwa, Osaka
Age
18 years and over
People
5
Run by
Takara Bio Inc.
See details and how to joinNCT07174427
Phase 1Taking people
Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
Where
Chuo Ku
Age
18 years and over
People
66 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07630961
Phase 1Taking people
AB122 Platform Study
Where
Aichi, Chiba, Ehime, Hokkaido, Kanagawa, Osaka, Shizuoka, Tokyo, Wakayama
Age
18 years and over
People
917
Run by
Taiho Pharmaceutical Co., Ltd.
See details and how to joinNCT04999761
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Chuo Ku, Kashiwa, Nagoya, Osaka, Sapporo, Tōon, Yokohama, Yonago
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
No phaseTaking people
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
Where
Nagoya
People
1,050 worldwide
Run by
Washington University School of Medicine
See details and how to joinNCT03141021
Phase 1/2Taking people
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Where
Chuo Ku, City
Age
18 years and over
People
27 worldwide
Run by
Tanabe Pharma America, Inc.
See details and how to joinNCT06943521
Phase 1/2Enrolling by invitation
Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA
Where
Osaka
Age
18 years to 85 years
People
30
Run by
Stella Pharma Corporation
See details and how to joinNCT06603987